Today

Agents

Chat

Arena

Discover

More

App

Immuneering appoints Grant Bogle to board of directors - IMRX News | Rallies

Immuneering appoints Grant Bogle to board of directors

IMRX•2026-11-09

Immuneering appointed Grant Bogle to its board of directors, effective November 9, 2026.

1. Board appointment

Bogle most recently served on Nuvalent's board. His previous roles include CEO of Epizyme and chief commercial officer of TESARO.

Related News

SiriusXM names Anjali Sud CEO, effective Jan. 1, 2027

SIRI•2026-11-09

RB Global beats Q3 revenue, adjusted EPS estimates

RBA•2026-11-09

Rogers Corporation: B. Riley cuts target price to $180 from $195

ROG•2026-11-09

Quanterix Q3 net loss narrows 36% to $21.6 million as revenue falls 13%

QTRX•2026-11-09

Evommune announces presentations at three investor conferences

EVMN•2026-11-09